Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis.
about
Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of MyeloperoxidaseClinical Relevance of Biomarkers of Oxidative StressInhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.2-Thioxanthines Are Mechanism-based Inactivators of Myeloperoxidase That Block Oxidative Stress during InflammationNebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosisRational drug design applied to myeloperoxidase inhibition.Specific sequence motifs direct the oxygenation and chlorination of tryptophan by myeloperoxidase.Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.Myeloperoxidase: a target for new drug development?Endpoints for clinical trials in young children with cystic fibrosis.Hyperinflammation in airways of cystic fibrosis patients: what's new?Oxidants and the pathogenesis of lung diseases.Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.Redox balance in cystic fibrosis.Cystic fibrosis-related oxidative stress and intestinal lipid disorders.Oxidation as an important factor of protein damage: Implications for Maillard reaction.Lifestyle predictors of oxidant and antioxidant enzyme activities and total antioxidant capacity in healthy women: a cross-sectional study.Antioxidant properties of cystic fibrosis sputum.Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.Azithromycin use in patients with cystic fibrosis.3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation.Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione.Simultaneous Measurement of 3-Chlorotyrosine and 3,5-Dichlorotyrosine in Whole Blood, Serum and Plasma by Isotope Dilution HPLC-MS-MS.Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other.Facile identification of photocleavable reactive metabolites and oxidative stress biomarkers in proteins via mass spectrometry.Increased arginase activity in cystic fibrosis airways.Cystic fibrosis, pediatrics, control of breathing, pulmonary physiology and anatomy, and surfactant biology in AJRCCM in 2004.Oxidative and endoplasmic reticulum stress in respiratory disease.
P2860
Q26767149-A2873DE9-DE53-48D3-90A9-59B0AAA686E0Q26785512-CD152640-5337-4F18-9EAC-88E8229A7FD9Q27325561-57DF369D-3CC5-4EE2-9EA4-3005A61F6111Q27672618-0F4FBEF9-7D4C-4E85-B3C2-81056AC30FD5Q28305590-69481EA6-73A2-47A7-9421-30BFD4601E57Q30372838-8FDB8B61-B5D1-4811-AA97-AAF431719447Q33237048-10D2EC53-097C-44AD-928D-DB9BDB81D1C9Q33475629-68CAC408-6E76-4508-B7DB-D5CC36BC12DAQ33862472-E745AA5F-FCB1-49BF-AF30-4A682746A25CQ36203126-9687A5D9-3C95-4DCE-AE6B-37C4BE01F07AQ36579774-C7BEFEC2-97E9-4520-95CC-E76635C69ED1Q36677933-8076860C-E6AB-4109-9815-1C229EA06DB9Q36860606-0BD97918-2157-4ACB-B473-7DB3A0B6DCB5Q36891557-9675D913-D8E4-4CDB-82A8-18C67831C0E0Q37206228-90591E78-647D-4176-AEEB-81F47B8DCDCDQ37219507-8AA267F7-7839-490C-9409-27CBC1D3E16CQ37246026-715496D4-1A00-4B69-9748-93B0517017DCQ37608445-ACF23A46-66C4-406A-99FA-21E211733DE0Q37839809-F60F28D9-4547-4011-AD0D-4759D90D930FQ37986199-13484993-6A85-4A05-914B-E254DE7257D4Q38198442-9FBBB2AC-B873-4906-8704-2A3508A5454FQ38328252-310501EF-0364-485F-87E4-4F57A1C2BBB4Q38473579-4D89F358-A2CC-48B3-8FC8-06BD75490B6AQ39413014-1A932DD4-AD8A-466A-879F-3A9DE37F7C61Q40473421-0D0AC024-D2A9-4C5F-AC71-178E0346396EQ41347561-809FE6C8-D4C9-429B-8CEA-611CF5158204Q41428470-FBBD36BB-12E6-4896-A16E-A141FBBFB215Q42776527-E087BE00-ECE5-47D4-9AEA-F711E80542ACQ43261587-9500A8A4-DF8F-47F3-B962-89FE546A4EF3Q45544845-B172BE0D-8E9D-4EE3-A234-5C80941D5349Q46230315-DB8E154A-6A5E-48A6-9AC7-F5A827154B80Q46320685-0E9FE47C-6B6A-4AE3-A9D4-62F977959024Q46706389-D691DB13-CD5C-4EAC-8C28-E546C7D07B61Q47836713-14C69419-3CAA-4EB3-9C5C-C3377001682FQ55233756-77EC1169-6F21-4F53-BDC0-4CDAA844DCDD
P2860
Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@en
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@nl
type
label
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@en
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@nl
prefLabel
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@en
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@nl
P2093
P2860
P1476
Myeloperoxidase and protein ox ...... children with cystic fibrosis.
@en
P2093
Anna L P Chapman
Anthony J Kettle
Iris Osberg
Jeffrey S Wagener
Revathy Senthilmohan
Tessa J Mocatta
Timothy Chan
P2860
P304
P356
10.1164/RCCM.200311-1516OC
P407
P577
2004-10-01T00:00:00Z